[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 12/10 on patient-focused drug development for fibromyalgia.[ Price : $8.95]
Federal Register Notice: FDAs Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will meet 10/30 to discuss s...[ Price : $8.95]
Federal Register Notice: FDAs Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will meet 10/31 to discuss c...[ Price : $8.95]
Federal Register Notice: FDA will hold a public workshop 1/8/14: Complex Issues in Developing Medical Devices for Pediatric Patien...[ Price : $8.95]
Federal Register Notice: CDER will co-sponsor a public workshop 10/26: Clinical Trial Design for Intravenous Fat Emulsion Products...[ Price : $8.95]
FDA issues Merck a Complete Response Letter on its NDA resubmission for sugammadex sodium injection, indicated for reversing neuro...[ Price : $8.95]
A citizen petition seeks a warning to the labeling of all nonprescription drug products containing an ingredient with anticholiner...[ Price : $8.95]
FDA denies a 21-year-old citizen petition seeking the market withdrawl of doxylamine succinate.